Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RELAPROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RELA (also known as p65) is the key transcriptional activator subunit of the Nuclear Factor kappa-B (NF-κB) transcription factor complex.
No AI portrait yet
| Gene Symbol | RELAPROTEIN |
| Full Name | RELA (p65) |
| Protein Type | Protein |
| Function | is a major driver of neuroinflammation, a hallmark pathological feature of Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). |
| Primary Expression | neurons, astrocytes, microglia, and oligodendrocytes, where it |
| Amino Acids | 300 aa |
| UniProt ID | Search UniProt |
| GeneCards | RELAPROTEIN |
| Human Protein Atlas | RELAPROTEIN |
| Rel Homology Domain (RHD) | The N-terminal ~300 amino acids comprise the RHD, which mediates DNA binding, dimerization, and interaction with IκB inhibitors |
| Transactivation Domain (TAD) | The C-terminal region contains two TADs (TAD1 and TAD2) that recruit transcriptional coactivators including CBP/p300 |
| RHD | Enables dimerization with p50, p52, c-Rel, or RELB to form functional NF-κB dimers |
| Inflammatory mediators | TNF-α, IL-1β, IL-6, COX-2, iNOS |
| Anti-apoptotic proteins | Bcl-2, Bcl-xL, c-IAP1/2, XIAP |
| Acute phase proteins | CRP, serum amyloid A |
| Associated Diseases | Aging, Als, Cancer, Glioblastoma, Hepatitis, Inflammation |
| Known Drugs/Compounds | RESVERATROL |
| Interactions | AKT, AKT1, ALZHEIMER, ALZHEIMER DISEASE, AMYLOID, AND |
| KG Connections | 755 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
RELAPROTEIN["RELAPROTEIN"]
neurodegeneration["neurodegeneration"]
RELAPROTEIN -->|"implicated_in"| neurodegeneration
style RELAPROTEIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning RELAPROTEIN in their description or question text
No additional research found